Alpha 2.0
Login Register
» Authors » Kris M Mahadeo

Kris M Mahadeo

Explore the profile of Kris M Mahadeo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 672
Followers 0
Related Specialties
Oncology
Pediatrics
Hematology
Top 10 Co-Authors
Priti Tewari
Hisham Abdel-Azim
Demetrios Petropoulos
Sajad Khazal
Julie C Fitzgerald
Courtney M Rowan
Dristhi Ragoonanan
Jennifer McArthur
Christine N Duncan
Shira J Gertz
Published In
Front Oncol
Biol Blood Marrow Transplant
Pediatr Blood Cancer
Pediatr Transplant
Blood Adv
Affiliations
Soon will be listed here.
Recent Articles
11.
Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant - how far we have come and how much further we must go
Agulnik A, Mahadeo K, Steiner M, McArthur J
Front Oncol . 2023 Mar; 13:1148321. PMID: 36910613
No abstract available.
12.
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Hines M, Knight T, McNerney K, Leick M, Jain T, Ahmed S, et al.
Transplant Cell Ther . 2023 Mar; 29(7):438.e1-438.e16. PMID: 36906275
T cell-mediated hyperinflammatory responses, such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), are now well-established toxicities of chimeric antigen receptor (CAR) T cell therapy. As...
13.
Prior COVID-19 infection may increase risk for developing endothelial dysfunction following hematopoietic cell transplantation
Ariagno S, Ragoonanan D, Khazal S, Mahadeo K, Cisneros G, Zinter M, et al.
Front Oncol . 2023 Feb; 12:1000215. PMID: 36733348
Endothelial dysfunction underlies many of the major complications following hematopoietic cell transplantation (HCT), including transplant-associated thrombotic microangiopathy (TA-TMA), veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS), and engraftment syndrome (ES). Emerging evidence similarly...
14.
Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease
Kinoshita H, Mandava M, Jensen-Wachspress M, Lang H, Joy E, Tanna J, et al.
Blood Adv . 2022 Dec; 7(10):2105-2116. PMID: 36516084
Hematopoietic stem cell transplantation (HSCT) is being increasingly used as a curative approach for sickle cell disease (SCD). With the risk of graft-versus-host disease (GVHD), especially in the human leukocyte...
15.
A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy
Ragoonanan D, Bhar S, Mohan G, Beltramo F, Khazal S, Hurley C, et al.
Front Oncol . 2022 Nov; 12:1022901. PMID: 36353531
Tisagenlecleucel is associated with remarkable outcomes in treating patients up to the age of 25 years with refractory B-cell acute lymphoblastic leukemia (ALL). Yet, due to unique and potentially life-threatening...
16.
The Evolution of Chimeric Antigen Receptor T-Cell Therapy in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukemia
Ragoonanan D, Sheikh I, Gupta S, Khazal S, Tewari P, Petropoulos D, et al.
Biomedicines . 2022 Sep; 10(9). PMID: 36140387
Chimeric antigen receptor T-cell (CAR T) therapy is a revolutionary treatment for pediatric, adolescent and young adult patients (AYA) with relapsed/refractory B-cell acute lymphoblastic leukemia. While the landscape of immunotherapy...
17.
Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia
Sheikh I, Alqahtani S, Ragoonanan D, Tewari P, Petropoulos D, Mahadeo K, et al.
Int J Mol Sci . 2022 Aug; 23(15). PMID: 35955881
Non-relapse mortality due to GVHD and infections represents a major source of morbidity and mortality in pediatric HSCT recipients. Post-transplant cyclophosphamide (PTCy) has emerged as an effective and safe GVHD...
18.
Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective
Sheikh I, Elgehiny A, Ragoonanan D, Mahadeo K, Nieto Y, Khazal S
Cancers (Basel) . 2022 Jun; 14(12). PMID: 35740580
Non-Hodgkin lymphoma (NHL) is a broad entity which comprises a number of different types of lymphomatous malignancies. In the pediatric and adolescent population, the type and prognosis of NHL varies...
19.
Noninvasive Ventilation Exposure Prior to Intubation in Pediatric Hematopoietic Cell Transplant Recipients
Cater D, Fitzgerald J, Gertz S, McArthur J, Daniel M, Mahadeo K, et al.
Respir Care . 2022 May; 67(9):1121-1128. PMID: 35640999
Background: Noninvasive ventilation (NIV) has become more studied in immunocompromised patients. However, it has not been studied in hematopoietic cell transplantation (HCT) recipients, who have higher mortality and higher pulmonary...
20.
Using the MDASI-Adolescent for Early Symptom Identification and Mitigation of Symptom Impact on Daily Living in Adolescent and Young Adult Stem Cell Transplant Patients
Sheikh I, Miller J, Shoberu B, Andersen C, Wang J, Williams L, et al.
Children (Basel) . 2022 Jan; 9(1). PMID: 35053644
Hematopoietic stem cell transplantation (HSCT) requires an intensive pre- and post-procedure course that leads to symptoms including fatigue, nausea/vomiting, and pain, all of which interfere significantly with activities of daily...